Clinical trials
Migraine Disorders trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 5 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IRCCS National Neurological Institute "C. Mondino" Foundation | 4 |
| University of Roma La Sapienza | 3 |
| ElectroCore INC | 2 |
| University of Florence | 2 |
| University of L'Aquila | 2 |
| Centro Cardiologico Monzino | 1 |
| Centro Universitario Ricerca Interdipartimentale Attivita' Motoria | 1 |
| European Institute for Evidence Based Osteopathic Medicine | 1 |
| IRCCS Sacro Cuore Don Calabria di Negrar | 1 |
| Istituto Auxologico Italiano | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 21 |
| Pain | 3 |
| Overweight | 2 |
| Brain Diseases | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Epilepsy | 1 |
| Foramen Ovale, Patent | 1 |
| Headache | 1 |
| Headache Disorders, Secondary | 1 |
| Joint Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.